GLS and neoplasm: found that by inhibiting both cellular constituents in this exchange, a combination strategy targeting glutamine synthetase in fibroblasts alongside glutaminase in cancer cells reduced tumor weight and metastatic burden in orthotopic mouse ovarian cancer models (23).